Dynamic Prognostic Value of IL‐6/PLT Ratio for Mortality Discrimination in Patients With Crimean‐Congo Hemorrhagic Fever: Sequential ROC Analysis Throughout the Clinical Course
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.71104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Murtaza Öz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Sivas Cumhuriyet University, Sivas, Türkiye. Hauptthemen laut MEDLINE: Hemorrhagic Fever, Crimean, Interleukin-6. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This study aimed to compare the prognostic performances of individual laboratory parameters and biomarker ratios derived from them formortality in patients with Crimean‐Congo Hemorrhagic Fever (CCHF), and to examine the temporal stability of the strongest index. A total of 1171 adult patients with laboratory‐confirmed CCHF followed between 2014 and 2024 were retrospectively included in the study. Admission data were recorded, and the mortality discriminative performances of individual and derived biomarkers (interleukin‐6‐to‐platelet ratio [IL‐6/PLT], interleukin‐6‐to‐calcium ratio [IL‐6/Ca], ferritin‐to‐platelet ratio [Ferritin/PLT], and ferritin‐to‐calcium ratio [Ferritin/Ca]) for mortality were compared using ROC analysis. Ninety‐seven patients (8.3%) resulted in mortality. Among the individual parameters, IL‐6 demonstrated the highest discriminative ability for mortality (AUC: 0.887). Among the derived indices, the IL‐6/PLT ratio demonstrated the highest overall performance with an AUC value of 0.920 (95% CI: 0.871–0.969; p < 0.001). The optimal cut‐off value for the IL‐6/PLT ratio was determined as 0.78 (88% sensitivity, 81% specificity). Mortality reached 100% in all patients with a ratio of ≥ 16. Sequential ROC analyzes demonstrated that the IL‐6/PLT ratio maintained high prognostic stability throughout the course of infection. The IL‐6/PLT ratio, a combined indicator of inflammatory response and hemostatic dysfunction, is a powerful biomarker candidate for the early and dynamic monitoring of mortality risk in CCHF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Sivas Cumhuriyet University, Sivas, Türkiye.
- Department of Biochemistry, Sivas Cumhuriyet University School of Medicine, Sivas, Türkiye.
ORCID-Profile: Murtaza Öz, Caner Öksüz, Ertuğrul Keskin, Rıdvan Karaarslan, Halef Okan Doğan, Seyit Ali Büyüktuna, Nazif Elaldi
Zitieren
APA
Öz, M., Öksüz, C., Keskin, E., Parlak, R., Dağci, E. İ., Tutku Bağ, Ç., Karaarslan, R., Doğan, H. O., Büyüktuna, S. A., & Elaldi, N. (2026). Dynamic Prognostic Value of IL‐6/PLT Ratio for Mortality Discrimination in Patients With Crimean‐Congo Hemorrhagic Fever: Sequential ROC Analysis Throughout the Clinical Course. Journal of Medical Virology. https://doi.org/10.1002/jmv.71104
Vancouver
Öz M, Öksüz C, Keskin E, Parlak R, Dağci Eİ, Tutku Bağ Ç, et al. Dynamic Prognostic Value of IL‐6/PLT Ratio for Mortality Discrimination in Patients With Crimean‐Congo Hemorrhagic Fever: Sequential ROC Analysis Throughout the Clinical Course. Journal of Medical Virology. 2026. doi:10.1002/jmv.71104
BibTeX
@article{z2026,
author = {Öz, Murtaza and Öksüz, Caner and Keskin, Ertuğrul and Parlak, Rüveyda and Dağci, Esra İrem and Tutku Bağ, Çiğdem and Karaarslan, Rıdvan and Doğan, Halef Okan and Büyüktuna, Seyit Ali and Elaldi, Nazif},
title = {Dynamic Prognostic Value of IL‐6/PLT Ratio for Mortality Discrimination in Patients With Crimean‐Congo Hemorrhagic Fever: Sequential ROC Analysis Throughout the Clinical Course},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71104}
}
EUVIMED